Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |   |
|---|---|
| Related links |  |
| Search |  |
Affiliation and department：
Job title： 教授
Homepage URL (2)： https://precision.kyushu-u.ac.jp , https://precision.kyushu-u.ac.jp/en/
Research theme for competitive and other funds (1)：
Papers (64)：
Education (2)：
Work history (9)：
Return to Previous Page
九州大学大学院医学研究院 プレシジョン医療学
About 九州大学大学院医学研究院 プレシジョン医療学
Job title： 教授
Homepage URL (2)： https://precision.kyushu-u.ac.jp , https://precision.kyushu-u.ac.jp/en/
Research theme for competitive and other funds (1)：
- 2020 - 2025 Development of novel therapeutic strategies for therapy-refractory leukemia
- Tatsuya Terasaki, Semba Y, Kensuke Sasaki, Hiroshi Imanaga, Setoguchi K, Yamauchi T, Shigeki Hirabayashi, Nakao F, Akahane K, Inukai T, et al. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells. Leukemia. 2024
- Ryo Yanagiya, Miyatake Y, Watanabe N, Shimizu T, Kanamori A, Masaya Ueno, Okabe S, Joaquim Carreras, Nakayama S, Hasegawa A, et al. Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia. Leukemia. 2024
- Hiroshi Imanaga, Yuichiro Semba, Kensuke Sasaki, Kiyoko Setoguchi, Hillary Maniriho, Takuji Yamauchi, Tatsuya Terasaki, Shigeki Hirabayashi, Fumihiko Nakao, Jumpei Nogami, et al. Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells. Blood Neoplasia. 2024
- Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, et al. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO Precision Oncology. 2024. 8
- Yasunori Kogure, Handa H, Yuta Ito, Masaki Ri, Horigome Y, Iino M, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, et al. ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone. Blood. 2024
- 1998 - 2001 名古屋大学大学院医学系研究科
- 1988 - 1994 名古屋大学医学部
- 2020/03 - 現在 九州大学大学院医学研究院 プレシジョン医療学
- 2016/10 - 2020/03 九州大学病院 遺伝子・細胞療法部
- 2011/09 - 2016/09 Brigham and Women's Hospital
- 2011/09 - 2016/09 Harvard Medical School
- 2007/01 - 2011/08 Beckman Research Institute of the City of Hope
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
